First Time Loading...

Mirati Therapeutics Inc
NASDAQ:MRTX

Watchlist Manager
Mirati Therapeutics Inc Logo
Mirati Therapeutics Inc
NASDAQ:MRTX
Watchlist
Price: 58.7 USD Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

1.1B
+23%
Assets
Growth Rates:
1 Year
-13%
3 Years
+82%
5 Years
+356%
7 Years
+1 326%
10 Years
+6 176%
183.2m
-2%
Liabilities
Growth Rates:
1 Year
+5%
3 Years
+166%
5 Years
+711%
7 Years
+1 237%
10 Years
+340%
946.5m
+30%
Equity
Growth Rates:
1 Year
-16%
3 Years
+72%
5 Years
+320%
7 Years
+1 345%
10 Years
-

Balance Sheet Decomposition
Mirati Therapeutics Inc

1.1B
Assets
183.2m
Liabilities
1.1B
Assets
183.2m
Liabilities
Current Assets 1B
Cash & Short-Term Investments 976.4m
Receivables 18m
Other Current Assets 41.7m
Non-Current Assets 93.6m
Long-Term Investments 27.8m
PP&E 51.1m
Intangibles 14.1m
Other Non-Current Assets 600k
Current Liabilities 137.4m
Accounts Payable 38m
Accrued Liabilities 99.4m
Non-Current Liabilities 45.8m
Other Non-Current Liabilities 45.8m

Balance Sheet
Mirati Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
14
7
50
22
108
33
47
886
413
235
Cash
0
0
0
0
1
4
1
20
19
53
Cash Equivalents
14
7
50
22
107
29
46
865
394
182
Short-Term Investments
48
23
73
34
43
190
369
505
1 078
849
Total Receivables
0
0
0
0
0
1
2
2
3
4
Accounts Receivables
0
0
0
0
0
0
0
0
0
1
Other Receivables
0
0
0
0
0
0
0
0
0
3
Inventory
0
0
0
0
0
0
0
0
0
3
Other Current Assets
2
3
3
3
5
3
8
11
14
18
Total Current Assets
64
33
125
60
156
227
424
1 404
1 508
1 109
PP&E Net
0
1
1
1
1
1
2
48
54
54
PP&E Gross
0
1
1
1
1
1
2
48
54
54
Accumulated Depreciation
3
0
0
1
1
1
1
2
3
6
Intangible Assets
0
0
0
0
0
0
0
0
0
15
Long-Term Investments
0
0
0
0
0
0
0
16
8
25
Other Long-Term Assets
0
0
2
3
1
1
5
9
19
1
Total Assets
65
N/A
34
-48%
128
+282%
63
-50%
157
+148%
229
+45%
432
+89%
1 476
+242%
1 589
+8%
1 203
-24%
Liabilities
Accounts Payable
1
2
2
6
4
9
16
18
35
39
Accrued Liabilities
4
4
8
9
9
17
32
53
109
121
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
33
0
0
0
0
0
0
0
0
0
Total Current Liabilities
39
5
10
15
14
26
49
72
144
159
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
1
1
44
48
47
Total Liabilities
39
N/A
5
-86%
10
+81%
15
+54%
14
-7%
27
+92%
50
+86%
115
+131%
192
+66%
206
+8%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
198
242
307
390
461
559
772
1 130
1 712
2 453
Additional Paid In Capital
215
261
415
429
594
751
1 145
2 481
3 100
3 453
Other Equity
10
10
10
10
10
10
10
10
9
4
Total Equity
26
N/A
28
+8%
118
+321%
48
-59%
143
+197%
202
+41%
382
+90%
1 361
+256%
1 397
+3%
997
-29%
Total Liabilities & Equity
65
N/A
34
-48%
128
+282%
63
-50%
157
+148%
229
+45%
432
+89%
1 476
+242%
1 589
+8%
1 203
-24%
Shares Outstanding
Common Shares Outstanding
13
14
19
20
29
33
40
50
55
58

See Also

Summary
MRTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRTX stock valuation using valuation multiples.
Wall Street Estimates
MRTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.